These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16320839)

  • 21. Tolerance induction during therapy with long-acting nitrates: how extensive is the "collateral damage"?
    Horowitz JD
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):11-12. PubMed ID: 15228054
    [No Abstract]   [Full Text] [Related]  

  • 22. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
    Schneider CA
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
    Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
    Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.
    Stokes GS; Bune AJ; Huon N; Barin ES
    Hypertension; 2005 Mar; 45(3):380-4. PubMed ID: 15699445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of once daily versus twice daily oral nitrates in stable angina pectoris.
    Kardas P;
    Am J Cardiol; 2004 Jul; 94(2):213-6. PubMed ID: 15246905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
    Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitrate therapy for stable angina pectoris.
    Parker JD; Parker JO
    N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
    Arthur RM; Mehmel H
    Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rationale for nitrates in angina pectoris.
    Held P; Olsson G
    Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring medical management of coronary artery disease: patient selection, optimal management, and potential problems for diagnosis.
    Cerqueira MD
    J Nucl Cardiol; 2000; 7(4):392-4. PubMed ID: 10958283
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina].
    Hamankiewicz M; Kucio C; Czapla J; Wójcik P
    Wiad Lek; 2001; 54(3-4):137-42. PubMed ID: 11436678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
    Arakawa K; Fujino M
    Clin Ther; 1980; 3(2):103-16. PubMed ID: 6778614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.